Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > TLT updated the corporate presentation Feb 7 2022

<< Previous

Bullboard Posts

Next >>

Comment by Yajneon Feb 14, 2022 9:48pm

192 Views

Post# 34428550

RE:TLT updated the corporate presentation Feb 7 2022

Thanks for 'heads up' on new Corporate deck. Very slick IMO. In the old days (pre-retirement) I would associate a presentation update with the company preparing to do a 'road show' for investors
Not sure if that is still the main reason these days, I guess we will soon see.

DJDawg wrote:
I'm sure there are some details in there that represent updates. They include BDT aproval in later 2022 which is interesting. Suggests may not be an imminent announcement but also suggests a high degree of confidence.

https://theralase.com/wp-content/uploads/2022/02/Corporate-PPT-020722.pdf

<< Previous

Bullboard Posts

Next >>

Rich TV Live's Stocks to Watch this week (Nov. 22, 2024)